
Peter on the importance of cancer screenings
This video clip is from AMA #25: Navigating the complexities and nuances of cancer screening, originally released on July 26,…

More than glycemic control: SGLT2 inhibitors may extend lung cancer survival
A retrospective study offers hope

Can a peptide found in bee stings offer hope for treatment-resistant breast cancers?
Melittin, the main component of honeybee venom, has shown promise as a basis for chemotherapeutic drugs to combat treatment-resistant breast cancer

Antitumor mRNA vaccines are cause for optimism
Moderna recently announced preliminary results of a clinical trial involving a personalized antitumor mRNA vaccine, and despite the knee-jerk uproar, the treatment may prove to be another useful weapon in the battle against cancer

Confusion over results of a recent colonoscopy trial
A recently published NEJM paper appears to show that colonoscopy screenings do not reduce risk of colorectal cancer death. As is often the case, the results have been taken out of context and their implications grossly overestimated.

Fighting cancer and improving immune function with sleep
This audio clip is from episode #48 with Matthew Walker, Ph.D., on sleep – Part II of III: Heart disease,…

#213 ‒ Liquid biopsies and cancer detection | Max Diehn, M.D. Ph.D.
“I was frustrated by not being able to diagnose a recurrence earlier.” —Max Diehn

Cumulative effects of LDL-C reduction in mitigating cardiovascular risk
Atherosclerotic cardiovascular disease (ASCVD) is currently the leading cause of death in the U.S. One of the most effective ways to reduce risk of ASCVD mortality is reduction of apoB particle number, typically estimated by LDL cholesterol (LDL-C) concentrations.